We refer to the Company’s announcements dated 19 August 2020, 24 August 2020, 27 August 2020, 2 September 2020, 23 September 2020 and 24 September 2020. The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that our subsidiary, Solution Biologics Sdn Bhd (“SOLBIO”), had on 30 October 2020 received a Letter of Authorisation (“LOA”) from CanSino Biologics Inc. (“CanSino”, SHSE: 688185, HKEX:06185).

The estimated 1 billion yearly output would be enough for China to meet domestic demand as well as supply foreign countries, Su said, noting that joining COVAX would also offer "double insurance" for China's vaccine supply.

Chinese companies also hailed the participation and actively prepare to expand production to meet international demand.

"The COVAX facility is especially important to developing countries as it ensures equal access to COVID-19 vaccines for both developed and developing countries," Dongxu Qiu, Senior Vice President and Co-Founder at CanSino Biologics Inc., said in an interview with CGTN on Friday.

so solutn ....gog oggogog

oppening 1.14

anthonytkh why?

hopping vs trust

price at support now 0.44

B4 29/08/2020

usedor1: agree with u. now we ar team mate